Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erenumab OLE in Chronic Migraine
NCT02174861Phase 2Completed
- Sponsor
- Amgen
- Start
- Jun 2014
- Primary completion
- May 2017
- Modality
- Monoclonal Antibodies
- Countries
- 10
01
Overview
A Phase 2 trial of erenumab in chronic migraine, sponsored by Amgen. Started Jun 2014; status: completed.
02
Drugs
erenumab
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT02174861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174861.